Differential Expression of Critical Cellular Genes in Human Lung Adenocarcinomas and Squamous Cell Carcinomas in Comparison to Normal Lung Tissues

Greenlee, 2001, Cancer Statistics, 2001, CA-Cancer J Clin, 51, 15, 10.3322/canjclin.51.1.15 Weinberg, 1989, Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis, Cancer Res, 49, 3713 Fearon, 1990, A genetic model for colorectal tumorigenesis, Cell, 61, 759, 10.1016/0092-8674(90)90186-I Pitterle, 1998, Hot spots for molecular genetic alterations in lung cancer, In Vivo, 12, 643 Wang, 1999, Role of p53 and apoptosis in carcinogenesis, Anticancer Res, 19, 4759 Sekido, 1998, Progress in understanding the molecular pathogenesis of human lung cancer, Biochim Biophys Acta, 1378, 21 Robbins, 1994, 673 Linnoila, 1995, 73 Jiang, 1995, Expression of Bcl-2 oncogene protein is prevalent in small cell lung carcinomas, J Pathol, 177, 135, 10.1002/path.1711770206 Jiang, 1996, Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation, Am J Pathol, 148, 837 Kaiser, 1996, Expression of Bcl-2-protein in small cell lung cancer, Lung Cancer, 15, 31, 10.1016/0169-5002(96)00568-5 Pezzella, 1993, Bcl-2 protein in nonsmall-cell lung carcinoma, N Engl J Med, 329, 690, 10.1056/NEJM199309023291003 Higashiyama, 1997, Bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis, J Surg Oncol, 64, 48, 10.1002/(SICI)1096-9098(199701)64:1<48::AID-JSO10>3.0.CO;2-S Reissmann, 1993, Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group, Oncogene, 8, 1913 Cagle, 1997, Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications, Am J Pathol, 150, 393 Dosaka-Akita, 1997, Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis, Cancer, 79, 1329, 10.1002/(SICI)1097-0142(19970401)79:7<1329::AID-CNCR9>3.0.CO;2-B Washimi, 1995, In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers, Cancer Res, 55, 514 Shapiro, 1995, Multiple mechanisms of p161NK4A inactivation in non-small cell lung cancer cell lines, Cancer Res, 55, 6200 Richardson, 1993, The biology of lung cancer, Semin Oncol, 20, 105 Eerola, 1997, Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity, J Pathol, 181, 172, 10.1002/(SICI)1096-9896(199702)181:2<172::AID-PATH715>3.0.CO;2-2 Nishio, 1996, Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers, J Clin Oncol, 14, 497, 10.1200/JCO.1996.14.2.497 Konishi, 1997, Association of p53 protein expression in stage I lung adenocarcinoma with reference to cytological subtypes, Hum Pathol, 28, 544, 10.1016/S0046-8177(97)90076-9 Kohno, 1999, How many tumor suppressor genes are involved in human lung carcinogenesis?, Carcinogenesis, 20, 1403, 10.1093/carcin/20.8.1403 Schwendel, 1997, Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations, Int J Cancer, 74, 86, 10.1002/(SICI)1097-0215(19970220)74:1<86::AID-IJC15>3.0.CO;2-G Testa, 1997, Advances in the analysis of chromosome alterations in human lung carcinomas, Cancer Genet Cytogenet, 95, 20, 10.1016/S0165-4608(96)00337-8 Clontech, 1999, I. Atlas cDNA Expression Arrays User Manual Clontech Laboratories, Inc., Palo Alto, CA, 4 Ashman, 1999, The biology of stem cell factor and its receptor Ckit, Int J Biochem Cell Biol, 31, 1037, 10.1016/S1357-2725(99)00076-X Sekido, 1993, Recombinant human stem cell factor mediates chemotaxis of small cell lung cancer cell lines aberrantly expressing the c-kit protooncogene, Cancer Res, 53, 1709 Krystal, 1996, Autocrine growth of small cell lung cancer mediated by coexpression of c- kit and stem cell factor, Cancer Res, 56, 370 Bredin, 1999, Growthfactor-dependent migration of human lung-cancer cells, Int J Cancer, 82, 338, 10.1002/(SICI)1097-0215(19990730)82:3<338::AID-IJC6>3.0.CO;2-Y Tonary, 2000, Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis, Int J Cancer, 89, 242, 10.1002/1097-0215(20000520)89:3<242::AID-IJC6>3.0.CO;2-6 Biscardi, 1999, c-Src, receptor tyrosine kinases, and human cancer, Adv Cancer Res, 76, 61, 10.1016/S0065-230X(08)60774-5 Mazurenko, 1991, The detection of the c-src protein gene product in human lung tumors, Vopr Onkol, 37, 683 Mazurenko, 1991, Synthesis and distribution of oncoproteins in tumor tissue, Vopr Med Khim, 37, 53 Budde, 1994, Activity of pp60c-src in 60 different cell lines derived from human tumors, Cancer Biochem Biophys, 14, 171 Leppa, 1999, Diverse functions of JNK signaling and c-Jun in stress response and apoptosis, Oncogene, 18, 6158, 10.1038/sj.onc.1203173 Koomagi, 1996, Expression of resistance-related proteins in tumoral and peritumoral tissues of patients with lung cancer, Cancer Lett, 110, 129, 10.1016/S0304-3835(96)04471-0 Levin, 1995, Expression patterns of immediate early transcription factors in human non-small cell lung cancer, The Lung Cancer Study Group. Oncogene, 11, 1261 Jiang, 1999, Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer, Crit Rev Oncol Hematol, 29, 209, 10.1016/S1040-8428(98)00019-5 Olivero, 1996, Overexpression and activation of hepatocyte growth factor/ scatter factor in human non-small-cell lung carcinomas, Br J Cancer, 74, 1862, 10.1038/bjc.1996.646 Miyazawa, 1996, Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator, J Biol Chem, 271, 3615, 10.1074/jbc.271.7.3615 Salomon, 1995, Epidermal growth factor-related peptides and their receptors in human malignancies, Crit Rev Oncol Hematol, 19, 183, 10.1016/1040-8428(94)00144-I Fontanini, 1998, Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival, Clin Cancer Res, 4, 241 Plowman, 1990, The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity, Mol Cell Biol, 10, 1969, 10.1128/MCB.10.5.1969 Shoyab, 1988, Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7, Proc Natl Acad Sci USA, 85, 6528, 10.1073/pnas.85.17.6528 Rusch, 1993, Differential expression of the epidermal growth factor receptor and its ligands in primary non small cell lung cancers and adjacent benign lung, Cancer Res, 53, 2379 Kalo, 1999, Signal transfer by Eph receptors, Cell Tissue Res, 298, 1, 10.1007/PL00008807 Nakamoto, 2000, Eph receptors and ephrins, IntJ Biochem Cell Biol, 32, 7, 10.1016/S1357-2725(99)00096-5 Pandey, 1995, Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alphainduced angiogenesis, Science, 268, 567, 10.1126/science.7536959 Daniel, 1996, ELK and LERK-2 in developing kidney and microvascular endothelial assembly, Kidney Int Suppl, 57, 73 Wang, 1998, Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4, Cell, 93, 741, 10.1016/S0092-8674(00)81436-1 Xu, 1997, Eph-related receptors and their ligands: mediators of contact dependent cell interactions, J Mol Med, 75, 576, 10.1007/s001090050142 Tapon, 1997, Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton, Curr Opin Cell Biol, 9, 86, 10.1016/S0955-0674(97)80156-1 Ridley, 1992, The small GTP-binding protein rac regulates growth factor-induced membrane ruffling, Cell, 70, 401, 10.1016/0092-8674(92)90164-8 Nobes, 1995, Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia, Cell, 81, 53, 10.1016/0092-8674(95)90370-4 Srinivasula, 1996, Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases, Proc Natl Acad Sci USA, 93, 14486, 10.1073/pnas.93.25.14486 Bratton, 2000, Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis, Exp Cell Res, 256, 27, 10.1006/excr.2000.4835 Teitz, 2000, Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN, Nat Med, 6, 529, 10.1038/75007 Soini, 1999, Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas, APMIS, 107, 1043, 10.1111/j.1699-0463.1999.tb01508.x Vakkala, 1999, Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion, Br J Cancer, 81, 592, 10.1038/sj.bjc.6690735 Virkajarvi, 1998, Apoptotic index and apoptosis influencing proteins Bcl-2, mcl-1, bax and caspases 3, 6 and 8 in pancreatic carcinoma, Histopathology, 33, 432, 10.1046/j.1365-2559.1998.00553.x Turunen, 2000, Apoptosis in gallbladder carcinomas and dysplasias, its relation to the expression of caspases 3, 6 and 8 and apoptosis regulating proteins Bcl-2, mcl-1 and bax, Histol Histopathol, 15, 53